Serum glucagon concentration and hyperinsulinaemia influence renal haemodynamics and urinary protein loss in normotensive patients with central obesity
Sb. Solerte et al., Serum glucagon concentration and hyperinsulinaemia influence renal haemodynamics and urinary protein loss in normotensive patients with central obesity, INT J OBES, 23(9), 1999, pp. 997-1003
OBJECTIVES: Insulin-resistance syndrome and hyperinsulinaemia are linked wi
th cardiovascular disease (CVD) in the obese population, In particular, car
diovascular risk is more frequent in central obesity and is associated with
microalbuminuria (MA). MA and changes of glomerular permeability to protei
ns in obesity might be related with renal haemodynamic modifications (that
is glomerular hyperfiltration). Since glucagon is physiologically involved
in renal haemodynamic regulation, the purpose of this study was to examine
whether changes of circulating glucagon levels might haemodynamically induc
e MA and proteinuria in patients with central obesity,
SUBJECTS: Forty normotensive obese out-patients, 22 with central (CO group)
and 18 with peripheral (PO group) body fat distribution and 11 healthy sub
jects.
MEASUREMENTS: Serum insulin and glucagon concentrations (fasting and after
oral glucose tolerance test (OGTT)) by radio immune assay (RIA); glomerular
filtration rate (GFR, isotopic); total clearances and urinary excretion ra
tes of albumin (AER), IgG (IgGER) and alpha 1 microglobulin (computerized i
mmunonephelometry).
RESULTS: GFR and insulin concentrations (fasting and during OGTT) were high
er in the CO than the PO group. Fasting glucagon concentrations were increa
sed, and not physiologically suppressed during OGTT in patients with CO (fa
sting, P < 0.05; OGTT 60 and 120 min, P < 0.001 vs PO group). Moreover, glu
cagon concentrations were significantly correlated with GFR in the CO group
(fasting, r = 0.49, P < 0.05; 60 min after OGTT, r = 0.58, P < 0.01); wher
eas no correlations were found in the PO group. Higher AER (P < 0.001), IgG
ER (P < 0.001) and alpha 1 microglobulin (P < 0.05) urinary concentrations
were found in patients with CO than in the PO group.
CONCLUSIONS: The increase of serum glucagon concentrations may be associate
d with the enhancement of GFR in patients with central obesity. Glomerular
hyperfiltration might influence the development of MA and of proteinuria by
means of a haemodynamic mechanism so contributing to increase the risk of
renal microvascular complications and of CVD in central obesity.